by John Conrad | Oct 1, 2024 | Member News
Endotronix, an Edwards Lifesciences company, has announced groundbreaking one-year clinical results for their Cordella Pulmonary Artery (PA) Sensor System, marking a significant advancement in heart failure management. The data, presented at the Heart Failure Society...
by John Conrad | Aug 2, 2024 | iBIO News
NewsBrief Weekly News Quiz: August 2nd Friday Biotech Buzz: Weekly Knowledge Challenge 🧬🔬 Calling all life science aficionados! It’s time for our weekly iBIO NewsBrief Quiz. How well have you kept up with the latest breakthroughs? Let’s put your...
by John Conrad | Jul 26, 2024 | iBIO News
NewsBrief Weekly News Quiz: July 26th Friday Biotech Buzz: Weekly Knowledge Challenge 🧬🔬 Calling all life science aficionados! It’s time for our weekly iBIO NewsBrief Quiz. How well have you kept up with the latest breakthroughs? Let’s put your...
by John Conrad | Jul 25, 2024 | iBIO in the News
Heart failure tech developer Endotronix is being acquired by Edwards Lifesciences a month after receiving regulatory approval for its implantable pulmonary artery sensor. Irvine, Calif.-based Edwards said in a press release it was exercising its option to acquire...
by John Conrad | Jul 24, 2024 | NewsBrief
In a significant development for Illinois’ healthcare technology sector, Â Endotronix has been acquired by Edwards Lifesciences, a global leader in patient-focused innovations for structural heart disease and critical care monitoring. This acquisition marks a...